Show simple item record

Thrombus Growth Under the Influence of Warfarin and After Abrupt Reversal of Its Effects

dc.contributor.authorZweifler, Andrew J.en_US
dc.date.accessioned2010-04-13T19:13:48Z
dc.date.available2010-04-13T19:13:48Z
dc.date.issued1968en_US
dc.identifier.citationZweifler, Andrew (1968). "Thrombus Growth Under the Influence of Warfarin and After Abrupt Reversal of Its Effects." Angiology 19(3): 135-140. <http://hdl.handle.net/2027.42/67188>en_US
dc.identifier.issn0003-3197en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/67188
dc.format.extent3108 bytes
dc.format.extent378212 bytes
dc.format.mimetypetext/plain
dc.format.mimetypeapplication/pdf
dc.publisherSage Publicationsen_US
dc.titleThrombus Growth Under the Influence of Warfarin and After Abrupt Reversal of Its Effectsen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialitiesen_US
dc.subject.hlbsecondlevelNursingen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumAssociate Professor of Medicine from Department of Internal Medicine, The University of Michigan Medical Center, Ann Arbor, Mich.en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/67188/2/10.1177_000331976801900301.pdf
dc.identifier.doi10.1177/000331976801900301en_US
dc.identifier.sourceAngiologyen_US
dc.identifier.citedreferenceMurphy, E.A., Mustard, J.F., Rowsell, H.C., and Downie, H.G.: Quantitative studies on the effect of Dicumarol on experimental thrombosis. J. Lab. Clin. Med., 61: 935, 1963.en_US
dc.identifier.citedreferenceCosgriff, S.W. : Chronic anticoagulant therapy in recurrent embolism of cardiac origin. Ann. Intern. Med., 38: 278, 1953.en_US
dc.identifier.citedreferenceKeyes, J.W., Drake, E.H., and Smith, F.J.: Survival rates after acute myocardial infarction with long-term anticoagulant therapy. Circulation, 14: 254, 1956.en_US
dc.identifier.citedreferenceCarter, S.A., Mc Devitt, E., Gatje, B.W., and Wright, J.S.: Analysis of factors affecting the recurrence of thromboembolism off and on anticoagulant therapy. Amer. J. Med., 25: 43, 1958.en_US
dc.identifier.citedreferenceDinon, L.R., and Vander Veir, J.B. : Recurrent myocardial infarction after cessation of anticoagulant therapy. Amer. Heart J., 60: 6, 1960.en_US
dc.identifier.citedreferenceZweifler, A.J., and Boddy, J.: Thrombus propagation in the carotid artery of the rabbit. Arch. Path. (Chicago), 80: 636, 1965.en_US
dc.identifier.citedreferenceQuick, A.J.: On quantitative estimation of prothrombin. Amer. J. Clin. Path., 15: 560, 1945.en_US
dc.identifier.citedreferenceAshwin, J.G.: The effect of drugs on experimental thrombogenesis. In Anticoagulants and Fibrinolysins, Toronto, 1961, edited by R. L. Mac Millan and J. F. Mustard, p. 117. The Mac Millan Company, New York, 1961.en_US
dc.identifier.citedreferenceDale, D.U., and Jaques, L.B.: The prevention of experimental thrombosis by dicumarin. Canad. Med. Ass. J., 46: 546, 1942.en_US
dc.identifier.citedreferenceThill, C., Stafford, W., Spooner, M., and Mayer, O.O.: Hemorrhagic agent 3,3'methylenebis (4-hydroxycoumarin). V. Its effect in prevention of experimental thrombosis. Proc. Soc. Exp. Biol. Med., 54: 333, 1943.en_US
dc.identifier.citedreferenceWright, H.P., Kubik, M., and Hayden: Recanalization of thrombosed arteries under anticoagulant therapy. Brit. Med. J., 1: 1021, 1953.en_US
dc.identifier.citedreferenceJewell, P., Pilkington, T., and Robinson, B.: Heparin and ethyl biscoumacetate in prevention of experimental venous thrombosis. Brit. Med. J., 1: 1013, 1954.en_US
dc.identifier.citedreferenceCarey, L.C., and Williams, R.D.: Comparative effects of dicumarol, tromexan and heparin on thrombus propagation. Ann. Surg., 152: 919, 1960.en_US
dc.identifier.citedreferenceDeykin, D., Wessler, S., and Reimer, S.M.: Evidence for an antithrombotic effect of dicumarol. Amer. J. Physiol., 199: 1161, 1960.en_US
dc.identifier.citedreferenceRowsell, H.C., Murphy, E.A., Glynn, M.F., and Mustard, J.F.: Adenosine nucleotides, platelets and thrombosis in swine. Blood, 25: 603, 1965.en_US
dc.identifier.citedreferenceSise, H.S., Moschos, C.B., Bauthier, J., and Becker, R.: The risk of interrupting long-term anticoagulant therapy. A rebound hypercoagulable state following hemorrhage. Circulation, 24: 1137, 1961.en_US
dc.identifier.citedreferenceSevitt, S., and Innes, M.B.: Evidence against "rebound" thrombosis after stopping oral anticoagulant drugs. Lancet, 2: 974, 1963.en_US
dc.identifier.citedreferenceVan Cleve, R.: The rebound phenomenon—fact or fancy? Circulation, 32: 878, 1965.en_US
dc.identifier.citedreferenceMc Ginty, D.A., Seegers, W.H., Pfeiffer, C.C., and Loew, E.R.: Plasma prothrombin concentration in dogs given 31-31-methylenebis (4-hydroxycoumarin) and purified beef prothrombin. Science, 96: 540, 1942.en_US
dc.identifier.citedreferenceLang, G., Pesic, R., Bach, D., and Fontaine, R.: La phase d'hypercoagulation qui suit l'arrit de l'administration de dicoumarol acetate d'ethyle (Tromexan). Presse Med., 69: 104, 1961.en_US
dc.identifier.citedreferenceCosgriff, S.W. : Chronic anticoagulant therapy in recurrent embolism of cardiac origin. Ann. Intern. Med., 38: 282, 1960.en_US
dc.identifier.citedreferenceZweifler, A.J., and Raccuglia, G.: Heparin retarded thrombelastography. Clin. Res., 8: 282, 1960.en_US
dc.identifier.citedreferenceCotton, R.C., and Wade, E.G.: Effect of sudden withdrawal of long-term anticoagulant therapy on the heparin resistance and plasma fibrinogen level. Clin. Sci., 26: 337, 1964.en_US
dc.identifier.citedreferencePoller, L., and Thomson, J.: Evidence for "rebound" hypercoagulability after stopping anticoagulants. Lancet, 2: 62, 1964.en_US
dc.identifier.citedreferenceMoschos, C.B., Sise, H.S., Becker, R., and Langer, R.: Study of a rebound hypercoagulable state after coumarin induced hemorrhage. Fed. Proc., 21: 62, 1962.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.